by Elena Iemma | Jun 23, 2026 | News
EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. The upgraded...
by Elena Iemma | Apr 30, 2025 | Events
The 17th annual Westin Immunogenicity Seminar Thursday, September 25, 2025 | 9:00 am – 6:00 pm | The Westin Hotel, Meguro, Tokyo Registration is closed Join us for the 17th Annual Westin Immunogenicity Seminar, a free event bringing together leaders in...
by Elena Iemma | Jan 23, 2024 | Blog
Where will we meet you in 2024? It’s Post-Pandemic and we’re back on the road traveling to the 4 corners of the Earth. Where will we get to see you? Here’s a list of upcoming conferences and events, and because … what’s travel without...
by Elena Iemma | May 16, 2023 | News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax...
by Elena Iemma | Jan 10, 2023 | News
PROVIDENCE, RI, January 10, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) and Zoetis, are pleased to announce an exclusive collaboration to develop CircoMatch™, a unique bioinformatics tool that predicts the coverage of Porcine Circovirus Type 2 (PCV2) vaccines...
